ScripsAmerica CEO Bob Schneiderman Featured on “Executive Leaders Radio”
13 February 2015 - 12:00AM
Business Wire
ScripsAmerica, Inc. (OTCBB: SCRC), a leading provider of a range
of specialty prescription and over the counter pharmaceuticals and
medical supplies, today announced that Bob Schneiderman, Chief
Executive Officer and Founding Partner, made a featured appearance
on “Executive Leaders Radio”, the #1 business weekly radio show in
the Mid-Atlantic States broadcast nationally on 91 terrestrial and
internet radio stations.
In his discussion with the show's host, Herb Cohen, Bob returns
to Philadelphia’s East Oak Lane neighborhood where he developed his
passion for business, the driving force behind the creation of
ScripsAmerica and Bob's commitment to building value for his
shareholders. Bob also touches on his philanthropy and the
importance of giving back to the community.
Bob’s interview can be heard Sunday, February 15 at 3 p.m. ET
via live stream at www.wche1520.com and on Sunday, February 22 at 7
a.m. ET at www.radioamerica.com or www.radioamerica.org.
For a full list of terrestrial stations please visit:
http://www.executiveleadersradio.com/executive-leaders-radio-show.aspx
A few weeks after the show airs it will be webcasted and
archived on the “Executive Leaders Radio” website at
http://www.executiveleadersradio.com/business-radio-schedule.aspx
The show can also be heard on iTunes, Podcastpickle.com,
Podbean.com and Castroller.com.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and
nutraceutical drugs, delivering pharmaceutical products to a wide
range of end users across the health care industry. End users
include retail pharmacies, hospitals, long-term care facilities and
government and home care agencies. For more information, visit
www.ScripsAmerica.com.
Gregory FCAJoe Hassett, 610-228-2110joeh@gregoryfca.com
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Jan 2025 to Feb 2025
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Feb 2024 to Feb 2025